In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug by BY REBECCA ROBBINS AND PAM BELLUCK

This entry was posted in Health Weight Watchers and tagged Health NYT on by

The agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms.

Published: July 8, 2021 at 07:54PM

from NYT Health https://ift.tt/3wpL7KI